In diabetes, some statins reduce non-HDL-C better than others vs. placebo

Ann Intern Med. 2022 Aug;175(8):JC89. doi: 10.7326/J22-0051. Epub 2022 Aug 2.

Abstract

Hodkinson A, Tsimpida D, Kontopantelis E, et al. Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis. BMJ. 2022;376:e067731. 35331984.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Comment

MeSH terms

  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / prevention & control
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Diabetes Mellitus* / drug therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors